Carregant...
A Systematic Review of Practice Guidelines and Recommendations for Discontinuation of Cholinesterase Inhibitors in Dementia
Cholinesterase inhibitors (ChEI) are the primary pharmacological treatment for symptom management of Alzheimer’s disease (AD), but they carry known risks during long-term use, and do not guarantee clinical effects over time. The balance of risks and benefits may warrant discontinuation at different...
Guardat en:
| Publicat a: | Am J Geriatr Psychiatry |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5817050/ https://ncbi.nlm.nih.gov/pubmed/29167065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jagp.2017.09.027 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|